A carregar...
Adalimumab for maintenance of remission in Crohn's disease
BACKGROUND: Conventional medications for Crohn's disease (CD) include anti‐inflammatory drugs, immunosuppressants and corticosteroids. If an individual does not respond, or loses response to first‐line treatments, then biologic therapies such as tumour necrosis factor‐alpha (TNF‐α) antagonists...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2020
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7386457/ https://ncbi.nlm.nih.gov/pubmed/32413933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012877.pub2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|